Roche is buying the shares it does not already own in US molecular information company Foundation Medicine (FMI), in a deal valued at $2.4 billion. More: Roche snaps up rest of Foundation Medicine for .4bn Source: News
read moreThe US Food and Drug Administration has rejected Valeant group Ortho Dermatologics’ plaque psoriasis therapy Duobrii. More: US regulators reject Valeant’s Duobrii Source: News
read moreA £56-million drug manufacturing innovation centre – the first of its kind in the world – has been announced for Renfrewshire in Scotland. More: Scotland to house world-first manufacturing innovation centre Source: News
read morePrime Minister Theresa May has confirmed that tax rises will be necessary to help fund the planned NHS budget increase. More: Tax rises on the horizon for NHS budget hike Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals